US Stock Market Move | Q1 revenue guidance lower than expected, CoreWeave (CRWV.US) plunges more than 12% in pre-market trading.
On Friday, CoreWeave (CRWV.US) plunged more than 12% in pre-market trading, to $85.57.
On Friday, CoreWeave (CRWV.US) plunged more than 12% in pre-market trading to $85.57. On the news front, CoreWeave reported a 110% year-on-year increase in fourth-quarter revenue to $1.57 billion, slightly exceeding the market's average expectation of $15.5 billion. The company reported a loss of 89 cents per share, which was lower than the market's average expectation. In terms of performance guidance, the company expects full-year revenue for 2026 to be between $12 billion and $13 billion, compared to analysts' previous expectations of $120.9 billion. Adjusted operating profit for 2026 is expected to be between $9 billion and $11 billion. However, revenue guidance for the first quarter is $19 billion to $20 billion, lower than the market consensus of $22.9 billion. The company plans to set its 2026 capital expenditure target at $30 billion to $35 billion, far exceeding the $103.1 billion in 2025.
CoreWeave CEO Mike Intrator stated: "Demand is shifting from initially focusing on super-scale cloud and infrastructure modeling to spreading across the entire economy. Enterprise demand is now growing explosively, sovereign domain demand is rising, and new entrants are entering the market to secure the necessary infrastructure."
Related Articles

STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.
STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


